ErzofriH(paliperidone palmitate)extended-releaseinjectable suspension

ErzofriH(paliperidone palmitate)extended-releaseinjectable suspension
Product Description

Treatment of schizophrenia in adults.Treatment of schizoaffective disorder in adults asmonotherapy and as an adjunct to mood stabilizersor antidepressants.

Read more Show less

Qingdao Luye SCO Pharmaceutical Technology Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1 - 24
Company types
Distributor/Import Export
View company profile
Categories
more categories Show less
Specifications
  • Details
    - 39 mg/0.25 mL;78 mg/0.5 mL;117 mg/0.75 mL;156 mg/mL;234 mg/1.5 mL;351 mg/2.25 mL-Treatment of schizophrenia in adults.Treatment of schizoaffective disorder in adults asmonotherapy and as an adjunct to mood stabilizersor antidepressants.
  • Supplied from
    China
More specifications Fewer specifications
Sales Markets
Show more Show less

Qingdao Luye SCO Pharmaceutical Technology Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    1 - 24
Company types
Distributor/Import Export
View company profile

More Products from Qingdao Luye SCO Pharmaceutical Technology Co., Ltd. (5)